Duties on life saving drugs hiked

The customs department hiked duty on bulk drugs such as Carbidopa and Cefoparazone to 10 per cent from five per cent

Image via Shutterstock
<a href="http://www.shutterstock.com/pic-228848833/stock-photo-pills-drug.html" target="_blank">Image</a> via Shutterstock
BS Reporter New Delhi
Last Updated : Feb 06 2016 | 1:22 AM IST
The government on Friday raised import duty on life saving and bulk drugs used to treat cancer, rabies, Parkinson's disease among others to help domestic players. The customs department hiked duty on bulk drugs such as Carbidopa and Cefoparazone to 10 per cent from five per cent.

Bulk drugs or active pharmaceutical ingredients (APIs) is the substance used for making the final medical formulations - drugs for consumption. The Modi government has already expressed its apprehension as India imports more than 80 per cent of its bulk drugs from China.

"An increase has also been made in the customs duty rates of certain life saving drugs such as Abciximab, Immunoglobulin, FSH, Procarbazine and Saquinavir to 35 per cent," said MS Mani, senior director, Deloitte in India.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 06 2016 | 12:55 AM IST

Next Story